Table: Rohto -9-MTH group results

Rohto Pharmaceutical

08/02/2017 06:00

Feb 8 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              111.42              120.32           150.50     
                   (-7.4 pct)          (+12.0 pct)      (-9.9 pct)   
  Operating           12.39               11.86            13.10     
                   (+4.5 pct)          (+31.7 pct)      (-16.5 pct)  
  Recurring           12.97               12.22            13.40     
                   (+6.1 pct)          (+26.7 pct)      (-12.6 pct)  
  Net                  8.41                7.81             7.50     
                   (+7.8 pct)          (+33.5 pct)      (-17.6 pct)  
  EPS               73.93 yen           68.69 yen        65.85 yen   
  EPS Diluted       73.62 yen           68.40 yen                    
  Ann Div                               20.00 yen        21.00 yen   
  -Q2 div           10.00 yen           10.00 yen                    
  -Q4 div                               10.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T 
  ((Tokyo Headline News Desk +813 6441 1812))